These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15700906)

  • 1. Exploring the potential link between Medicaid access restrictions, physician location, and health disparities.
    Headen A; Masia N
    Am J Manag Care; 2005 Jan; 11 Spec No():SP21-6. PubMed ID: 15700906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of access restrictions on the vintage of drugs used by Medicaid enrollees.
    Lichtenberg FR
    Am J Manag Care; 2005 Jan; 11 Spec No():SP7-13. PubMed ID: 15700904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
    Morrato EH; Staffa JA
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why worry about restricting access to medicines in Medicaid?
    Burroughs VJ
    Am J Manag Care; 2005 Jan; 11 Spec No():SP4-5. PubMed ID: 15700903
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.
    Shireman TI; Rigler SK
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):210-8. PubMed ID: 17062321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Medicaid claims data to evaluate a large physician fee increase.
    Fox MH; Phua KL
    Health Serv Res; 1994 Aug; 29(3):315-40. PubMed ID: 8063568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of the impact of preferred drug lists on hospital and physician visits and the costs to Medicaid.
    Murawski MM; Abdelgawad T
    Am J Manag Care; 2005 Jan; 11 Spec No():SP35-42. PubMed ID: 15700908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary.
    Wang YR; Pauly MV; Lin YA
    Am J Manag Care; 2003 Oct; 9(10):686-96. PubMed ID: 14572179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
    Quigley HA; Friedman DS; Hahn SR
    Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between pharmacy closures and prescription drug use: a retrospective analysis of Medicaid prescription claims in Iowa.
    Xiao H; Sorofman B; Manasse HR
    Am J Manag Care; 2000 Mar; 6(3):366-72. PubMed ID: 10977436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
    Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicaid preferred drug lists' costs to physicians.
    Ketcham JD; Epstein AJ
    Med Care; 2008 Jan; 46(1):9-16. PubMed ID: 18162850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Law, medicine, and wealth: does concierge medicine promote health care choice, or is it a barrier to access?
    Carnahan SJ
    Stanford Law Pol Rev; 2006; 17(1):121-63. PubMed ID: 17165233
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly.
    Starner CI; Norman SA; Reynolds RG; Gleason PP
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):11-9. PubMed ID: 19281936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How effectively do managed care organizations influence prescribing and dispensing decisions?
    Carroll NV
    Am J Manag Care; 2002 Dec; 8(12):1041-54. PubMed ID: 12500881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of medicaid access restrictions on statin utilisation for patients treated by physicians practising in poor and minority neighbourhoods.
    Headen AE; Masia NA; Axelsen KJ
    Pharmacoeconomics; 2006; 24 Suppl 3():41-53. PubMed ID: 17266387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age, sex, and race on prescription drug use among Georgia Medicaid recipients.
    Kotzan L; Carroll NV; Kotzan JA
    Am J Hosp Pharm; 1989 Feb; 46(2):287-90. PubMed ID: 2653026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to orthopaedic care for children with medicaid versus private insurance: results of a national survey.
    Skaggs DL; Lehmann CL; Rice C; Killelea BK; Bauer RM; Kay RM; Vitale MG
    J Pediatr Orthop; 2006; 26(3):400-4. PubMed ID: 16670556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.